We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+30.8%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$212M
AUM Growth
+$27.2M
Cap. Flow
+$3.14M
Cap. Flow %
1.48%
Top 10 Hldgs %
37.06%
Holding
250
New
12
Increased
32
Reduced
51
Closed
14

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.71M
2
FEZ icon
State Street SPDR EURO STOXX 50 ETF
FEZ
+$4.35M
3
FMC icon
FMC
FMC
+$865K
4
BP icon
BP
BP
+$468K
5
CVX icon
Chevron
CVX
+$429K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.28M
2
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$1.52M
3
MNDT
Mandiant, Inc. Common Stock
MNDT
+$806K
4
OXY icon
Occidental Petroleum
OXY
+$635K
5
BMY icon
Bristol-Myers Squibb
BMY
+$477K

Sector Composition

Rank Sector Weight
1 Healthcare 20.78%
2 Technology 16.62%
3 Financials 15.72%
4 Energy 10.48%
5 Industrials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
201
Insulet
PODD
$11.5B
$6K ﹤0.01%
35
– –
RTX icon
202
RTX Corp
RTX
$290B
$6K ﹤0.01%
60
– –
RWK icon
203
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.31B
$6K ﹤0.01%
100
– –
TMO icon
204
Thermo Fisher Scientific
TMO
$213B
$6K ﹤0.01%
20
– –
UL icon
205
Unilever
UL
$137B
$6K ﹤0.01%
90
– –
WAT icon
206
Waters Corp
WAT
$37B
$6K ﹤0.01%
25
– –
ZTS icon
207
Zoetis
ZTS
$32.4B
$6K ﹤0.01%
47
– –
XYZ
208
Block Inc
XYZ
$48.4B
$6K ﹤0.01%
100
– –
TRQ
209
DELISTED
Turquoise Hill Resources Ltd
TRQ
$6K ﹤0.01%
800
+400
+100% +$2.06K
CRM icon
210
Salesforce
CRM
$151B
$5K ﹤0.01%
30
– –
NTRS icon
211
Northern Trust
NTRS
$33.3B
$5K ﹤0.01%
50
– –
GWPH
212
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5K ﹤0.01%
50
– –
ACA icon
213
Arcosa
ACA
$7.13B
$4K ﹤0.01%
100
– –
DEO icon
214
Diageo
DEO
$49B
$4K ﹤0.01%
25
– –
KMI icon
215
Kinder Morgan
KMI
$71.7B
$4K ﹤0.01%
200
– –
MTD icon
216
Mettler-Toledo International
MTD
$28.6B
$4K ﹤0.01%
5
– –
FATE icon
217
Fate Therapeutics
FATE
$286M
$3K ﹤0.01%
175
-825
-83% -$13.1K
GLMD icon
218
Galmed Pharmaceuticals
GLMD
$5.13M
$3K ﹤0.01%
3
– –
JWN
219
DELISTED
Nordstrom
JWN
$3K ﹤0.01%
78
– –
RWJ icon
220
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.05B
$3K ﹤0.01%
150
– –
UAA icon
221
Under Armour
UAA
$2.84B
$3K ﹤0.01%
150
– –
BBL
222
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$3K ﹤0.01%
67
– –
CGC
223
Canopy Growth
CGC
$387M
$2K ﹤0.01%
10
– –
BABA icon
224
Alibaba
BABA
$293B
$1K ﹤0.01%
5
+1
+25% +$188
PIPR icon
225
Piper Sandler
PIPR
$5.12B
$1K ﹤0.01%
48
– –
6 7 8
9
10

Similar funds

AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return

Bourgeon Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Bourgeon Capital Management held 250 positions worth $212M, up 15% from $185M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bourgeon Capital Management's Q4 2019 filing shows 12 new, 32 increased, 51 reduced and 14 closed positions. Its largest new stake was State Street SPDR EURO STOXX 50 ETF: 110,605 shares worth $4.51M. The largest sale was Merck, an estimated $2.28M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Bourgeon Capital Management's largest Q4 2019 buy was State Street SPDR EURO STOXX 50 ETF: 110,605 shares worth $4.51M.
  • Bourgeon Capital Management added most to NVIDIA in Q4 2019, an estimated $4.71M increase.
  • Bourgeon Capital Management's biggest Q4 2019 reduction was Merck, cutting an estimated $2.28M.
  • Bourgeon Capital Management fully exited Occidental Petroleum in Q4 2019, selling an estimated $635K.
  • Bourgeon Capital Management's ten largest holdings make up 37% of its $212M portfolio in Q4 2019.
  • Bourgeon Capital Management opened 12 new positions and closed 14 in Q4 2019.
  • Bourgeon Capital Management's portfolio value rose 15% quarter-over-quarter to $212M.

Based on Bourgeon Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.